Two pathogenic variants in TUBA1A have been reported at this residue, V409I and V409A, identified in individuals with pachygyria and agyria (mild and severe lissencephaly) respectively (Bahi-Buisson et al., 2014; Fallet-Bianco et al., 2014). Here, TUBA1A is linked to Lissencephaly.